Torthaí cuardaigh - Baselga, Josè

Pharmacology in the Era of Targeted Therapies: The Case of PI3K Inhibitors de réir Toska, Eneda, Baselga, José

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Targeted therapies for breast cancer de réir Higgins, Michaela J., Baselga, José

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Molecular Pathways: AXL, a Membrane Receptor Mediator of Resistance to Therapy de réir Scaltriti, Maurizio, Elkabets, Moshe, Baselga, José

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Deconstructing feedback-signaling networks to improve anticancer therapy with mTORC1 inhibitors de réir Carracedo, Arkaitz, Baselga, Jose, Pandolfi, Pier Paolo

Faigh an téacs iomlán Faigh an téacs iomlán

Treatment of HER2-Positive Metastatic Breast Cancer de réir Swain, Sandra M., Clark, Emma, Baselga, José

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Implementing Genome-Driven Oncology de réir Hyman, David M., Taylor, Barry S., Baselga, José

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

A view on drug resistance in cancer de réir Vasan, Neil, Baselga, José, Hyman, David M.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silico based mechanism de réir Fuentes, Gloria, Scaltriti, Maurizio, Baselga, José, Verma, Chandra S

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Advances in the management of HER2-positive early breast cancer de réir Baselga, José, Coleman, Robert E., Cortés, Javier, Janni, Wolfgang

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Pancancer modelling predicts the context-specific impact of somatic mutations on transcriptional programs de réir Osmanbeyoglu, Hatice U., Toska, Eneda, Chan, Carmen, Baselga, José, Leslie, Christina S.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Unconventional Secretion is a Major Contributor of Cancer Cell Line Secretomes de réir Villarreal, Laura, Méndez, Olga, Salvans, Cándida, Gregori, Josep, Baselga, José, Villanueva, Josep

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

The Carboxy-terminal Cysteine of the Tetraspanin L6 Antigen Is Required for Its Interaction with SITAC, a Novel PDZ Protein de réir Borrell-Pagès, Maria, Fernández-Larrea, Juan, Borroto, Aldo, Rojo, Federico, Baselga, José, Arribas, Joaquín

Faigh an téacs iomlán Faigh an téacs iomlán

Proteomic Identification of Desmoglein 2 and Activated Leukocyte Cell Adhesion Molecule as Substrates of ADAM17 and ADAM10 by Difference Gel Electrophoresis de réir Bech-Serra, Joan J., Santiago-Josefat, Belén, Esselens, Cary, Saftig, Paul, Baselga, José, Arribas, Joaquín, Canals, Francesc

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Biosynthesis of tumorigenic HER2 C-terminal fragments by alternative initiation of translation de réir Anido, Judit, Scaltriti, Maurizio, Bech Serra, Joan Josep, Josefat, Belén Santiago, Rojo Todo, Federico, Baselga, José, Arribas, Joaquín

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Differential Receptor Tyrosine Kinase PET Imaging for Therapeutic Guidance de réir Wehrenberg-Klee, Eric, Turker, N. Selcan, Heidari, Pedram, Larimer, Benjamin, Juric, Dejan, Baselga, José, Scaltriti, Maurizio, Mahmood, Umar

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-cont... de réir Miles, David, Baselga, José, Amadori, Dino, Sunpaweravong, Patrapim, Semiglazov, Vladimir, Knott, Adam, Clark, Emma, Ross, Graham, Swain, Sandra M.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx: A Secondary Analysis of a Randomized Clinical Trial de réir Bonner, James, Giralt, Jordi, Harari, Paul, Spencer, Sharon, Schulten, Jeltje, Hossain, Anwar, Chang, Shao-Chun, Chin, Steve, Baselga, José

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

TARGETING THE MUC1-C ONCOPROTEIN DOWNREGULATES HER2 ACTIVATION AND ABROGATES TRASTUZUMAB RESISTANCE IN BREAST CANCER CELLS de réir Raina, Deepak, Uchida, Yasumitsu, Kharbanda, Akriti, Rajabi, Hasan, Panchamoorthy, Govind, Jin, Caining, Kharbanda, Surender, Scaltriti, Maurizio, Baselga, Jose, Kufe, Donald

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Molecular Features and Survival Outcomes of the Intrinsic Subtypes Within HER2-Positive Breast Cancer de réir Prat, Aleix, Carey, Lisa A., Adamo, Barbara, Vidal, Maria, Tabernero, Josep, Cortés, Javier, Parker, Joel S., Perou, Charles M., Baselga, José

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors de réir Jonas, Oliver, Landry, Heather M., Fuller, Jason E., Santini, John T., Baselga, Jose, Tepper, Robert I., Cima, Michael J., Langer, Robert

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán